Get intelligentvalue.com

Own it today or select a payment plan

Buy Now$3,879Payment Plan$325/mo

Secured by Stripe

Premium Domain Name

intelligentvalue.com

is available for purchase

51 views

Visitors from

US 54%·

AU 32%·

IN 7%·

GB 2%·

FR 2%

Perfect for

Financial Consulting Technology Startups Educational Services Economic Forecasting E-commerce Solutions Business Analytics Artificial Intelligence Solutions Investment Advisory Strategic Planning Market Research

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

International Sales Win for PUR Biologics

October 24, 2023 at 05:00 AM EDT

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

PUR Biologics' robust distribution channels prove to expand sales globally.

IRVINE, CA / ACCESSWIRE / October 24, 2023 / Following a successful engagement at the North American Spine Society (NASS) conference, healthcare technology company, HippoFi, Inc. (OTC PINK:ORHB), announces its wholly owned subsidiary, PUR Biologics, has expanded its sales to include several notable international healthcare establishments.

Ryan Fernan, the Head of PUR Biologics, stated, "Our recent ventures with ZIMMER BIOMET and Italian company BPB Medica, have evoked broader international attention. It's affirming to see our expertise in spinal biologics and innovation garner global acknowledgment."

CJ Wiggins, Executive Chairman and CEO of HippoFi, added, "The power of our distribution channels is a core component to the design of our business, providing us deep coverage and a source of revenue opportunities for our spinal biologic products."

With PUR Biologics' clear trajectory of leadership in the biotech sector, there is incredible momentum building.

To learn more about PUR Biologics' full line of biologic products, visit www.PURbiologics.com.

----

About PUR Biologics

PUR Biologics, a wholly owned subsidiary of HippoFi, Inc. (OTC PINK:ORHB), is a leading biologic company committed to supporting surgeons and hospitals in providing the best care for their patients. PUR Biologics' full line of biologic products currently include: advanced allografts and demineralized extracellular matrixes (d-ECM), innovative synthetic solutions, cellular derived tissues, and a future of next generation regenerative stem cell and growth factor driven therapeutics for treating osteoarthritis and cartilage regeneration.

About HippoFi, Inc.

HippoFi, Inc. delivers its cutting-edge healthcare innovations through an extensive sales channel network while implementing first-to-market solutions in the multibillion-dollar Biotech, Fintech, and Artificial Intelligence (AI) markets. HippoFi comprises three segments: Regenerative Therapeutics, Digital Payments, and AI, which utilize the same customer channels to commercialize solutions, drive revenue, and improve patient outcomes.

HippoFi, Inc. is publicly traded under the symbol: ORHB and is headquartered in Irvine, California. For more information, please visit: www.HippoFi.com and www.PURbiologics.com.

Contact

HippoFi, Inc.
949-323-2330
info@hippofi.com

SOURCE: HippoFi, Inc.

View source version on accesswire.com:
https://www.accesswire.com/795854/international-sales-win-for-pur-biologics

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article